Although a growing body of evidence demonstrates that the ALT mechanism is a post-replicative telomere recombination process, molecular details of this pathway are largely unknown. Here we demonstrate that MUS81, a DNA structure specific recombination endonuclease, has a key role in the maintenance of telomeres in human ALT cells. We find that MUS81 specifically localizes to ALT-associated promyelocytic leukaemia (PML) nuclear bodies (APBs) and associates with telomeric DNA in ALT cells, which is enriched during the G2 phase of the cell cycle. Depletion of MUS81 results in the reduction of ALTspecific telomere recombination and leads to proliferation arrest of ALT cells. In addition, the endonuclease activity of MUS81 is required for recombination-based ALT cell survival, and the interaction of MUS81 with the telomeric repeat-binding factor TRF2 regulates this enzymatic activity, thereby maintaining telomere recombination. Thus, our results suggest that MUS81 is involved in the maintenance of ALT cell survival at least in part by homologous recombination of telomeres.
Homologous recombination of telomeres is implicated in the ALT pathway [1] [2] [3] [4] . Increased telomere recombination is ALT-specific and extends the proliferative life of ALT cells 5 . Homologous recombination-associated proteins and telomere-associated proteins colocalize with telomeric DNA at APBs, which are present only in ALT cells [6] [7] [8] [9] . Additionally, APBs are enriched during the G2 phase of the cell cycle when homologous recombination is most active and ALT activity is occurring 10, 11 . MUS81 functions as an endonuclease by cleaving various DNA substrates [12] [13] [14] [15] [16] [17] and is required for the survival of cells undergoing aberrant replication and recombination 12, 14, 17, 18 , suggesting that it may be a candidate ' ALT protein' involved in abnormal telomere recombination in ALT cells. Here we report that MUS81 associates specifically with telomeres in ALT cells and is essential for ALT cell viability through regulation of telomere recombination.
APBs are found in < 5% of asynchronously growing ALT cells and are detected by visualizing the large TRF1 or TRF2 foci, which appear much brighter than individual telomeres [6] [7] [8] [9] . We confirmed the observation that TRF1, TRF2 and telomeric DNA colocalized with PML in APBs of ALTpositive human GM847 cells ( Supplementary Information, Fig. S1A ). Next, we examined the nuclear localization of MUS81 in an asynchronous GM847 cell culture and found that MUS81 formed discrete nuclear foci specifically in APB-positive cells: MUS81 foci were not seen in APBnegative cells. These MUS81 foci colocalized with telomeric DNA and PML in APBs in < 5% of GM847 cells (Fig. 1a) . The presence of MUS81 in APBs was also confirmed in another ALT cell line, U2OS (Fig. 1b) . The foci were specific to MUS81, as depletion of MUS81 led to their disappearance ( Supplementary Information, Fig. S1B ). These results indicate that MUS81 is an integral component of APBs in human ALT-positive cells.
To determine whether the association of MUS81 with APBs is cell-cycle dependent, we examined MUS81 foci formation during different phases of the cell cycle. GM847 cells that had been synchronized at the G1/S boundary by a double thymidine block were released into the cell cycle before being fixed at specific times. FACS analysis confirmed cell-cycle distributions ( Supplementary Information, Fig. S1C ). Consistent with previous reports 10, 11 , < 5% of GM847 cells had APBs during G1/S and S, and we only observed MUS81 foci in APBs ( Fig. 1c ). At G2 ~ 40% of cells showed MUS81 foci colocalized with APBs. When arrested at S-phase with hydroxyurea < 5% of cells had MUS81 foci. Taken together, our results demonstrate that the association of MUS81 with APBs is enriched at G2. GM847 cells arrested in G0/G1 by methionine restriction showed induced APBs in 50-60% of the population 9 (Fig. 1c ). However, MUS81 colocalized to < 5% of APBs (original APBs), not to the large population of induced APBs. Thus, we conclude that MUS81 foci formation was only enriched in APBs at G2 phase. The abundance of MUS81 was not increased in G2 of ALT cells (Fig. 1c; bottom) , indicating that MUS81 may be recruited to APBs in ALT cells.
It has been demonstrated that MUS81 localizes to nucleoli in human telomerase-positive (non-ALT) cells 19 . We observed diffuse staining of MUS81 throughout the nucleoli in non-ALT human fibrosarcoma HT1080 cells and also in ALT cells ( Supplementary Information,  Fig. S1D, E ), suggesting that MUS81 localizes to both APBs and nucleoli in ALT cells. Interestingly, co-localization of MUS81 with telomeric DNA was not observed in non-ALT cells (HT1080), suggesting that MUS81 may contribute to telomere maintenance only in ALT cells. Chromatin immunoprecipitation (ChIP) assays were performed to determine the association of MUS81 with telomeric DNA. We observed an enrichment of telomeric DNA co-immunoprecipitated with an anti-MUS81 antibody in ALT cells ( Fig. 1d ), suggesting that MUS81 binds to telomeres. MUS81 depletion decreased the telomeric DNA signal, indicating the specificity of the ChIP assay for MUS81. We did not detect the telomeric DNA signal with the ani-MUS81 antibody in non-ALT MCF7 cells, consistent with the immunostaining results showing that MUS81 associates were prepared and stained with FITC-labelled telomere PNA probe (green) and DNA was stained with DAPI (blue). The arrows point to telomere loss. Quantitative data (right) indicates that free-end telomeres increased to ~15% in the shMUS81A and shMUS81B groups and 6% in the shGFP control group. Data are mean ± s.d. from three independent experiments. (c) Knockdown of MUS81 decreases the rate of T-SCE in GM847 cells. BrdU (30 μM) was incorporated, for one round of DNA replication (~26 h), into GM847 cells that had been expressing shMUS81 (or cells transfected with an empty vector, control) for one week. T-SCE was detected with a telomeric G-strand PNA probe (red) and a C-strand PNA probe (green). Arrows show telomere exchange signals (yellow). Data are mean ± s.d. from three independent experiments. P values in a-c were determined by Student's t test. Scale bars, 2 µm in b and c. with telomeres specifically in ALT cells. The immunostaining results indicate localization of MUS81 to APBs was specifically enriched during G2. Telomere ChIP assays with an anti-MUS81 antibody in U2OS cells led to the recovery of 5'-TTAGGG-3' repeats in extracts from G2 cells ( Fig. 1e ). We observed a significant enrichment in telomeric DNA co-immunoprecipitated with an anti-MUS81 antibody from G2 cells. These results confirm that association of MUS81 with telomeres in APBs is enriched in G2.
Next, we examined the role of MUS81 in ALT cell proliferation. Depletion of MUS81 caused growth arrest in most ALT cells within 3-4 weeks. Colony-formation assays showed that MUS81 short hairpin RNA (shMUS81) markedly induced cell growth arrest in three ALT cell lines (GM847, U2OS and SAOS-2; Fig. 2a ; Supplementary Information, Fig. S2A ). Inhibition of MUS81 expression in non-ALT cells (HT1080 and MCF7) only decreased cell viability to ~ 60%, suggesting that the effect of MUS81 on cell viability is specific to ALT cells. Consistently, a significant decrease in bromodeoxyuridine (BrdU, a synthetic analogue of thymidine) incorporation was associated with a reduction of MUS81 levels in ALT cells, but not in non-ALT cells ( Supplementary  Information, Fig. S2B ). From these results, we conclude that MUS81 has a key role in the proliferation of ALT cells.
The effect of MUS81 depletion on cell-cycle progression was analysed using FACS ( Supplementary Information, Fig. S3A ). Knockdown of MUS81 in ALT cells induced a diffused pattern of S and G2, suggesting that depletion of MUS81 induces defective S. There was no significant change in shMUS81-expressing HT1080 cells. In addition, apoptosis did not increase in ALT or non-ALT cells after depletion of MUS81 ( Supplementary Information, Fig. S3B ). These data suggest that MUS81 may mediate ALT cell proliferation by regulating the cell cycle.
To further investigate the role of MUS81 in telomere maintenance, we conducted a telomere fluorescence in situ hybridization (FISH) assay in GM847 cells. An elevated frequency of telomere signal loss (15% per chromosome) was observed in shMUS81-transduced cells (Fig. 2b ).This was approximately threefold higher than that of control cells (5% per chromosome, P < 0.001). Thus, depletion of MUS81 leads to increased loss of telomere signals.
Telomere sister chromatid exchange (T-SCE), a hallmark of ALT cells, is associated with telomere recombination and ALT cell proliferation 2, 5, 8 . To test whether depletion of MUS81 hinders telomere recombination, we monitored the frequency of T-SCE in GM847 cells by performing chromosome orientation (CO)-FISH. Consistent with previous reports 2, 5 , we observed that a substantial proportion of metaphases had many chromosome extremities bearing 'double signals' (Fig. 2c ; yellow). Quantitative analysis showed that GM847 cells had ~ 15% frequency of T-SCE. Notably, depletion of MUS81 decreased the frequency to ~ 5%. Depletion of MUS81 also decreased the frequency of T-SCE in other ALT cells by a similar amount (U2OS and SAOS-2), demonstrating that MUS81 participates in T-SCE of ALT cells.
To investigate the effect of MUS81 on global telomere maintenance, we analysed telomere loss and T-SCE in non-ALT cells. MUS81-knockdown in HT1080 and MCF7 cells did not induce telomere loss, nor did it affect the rate of T-SCE ( Supplementary Information, Fig. S4 ). Moreover, Mus81-deficient mouse embryonic fibroblasts (MEFs) did not show telomere loss or T-SCE phenotypes, confirming that MUS81 may not be involved in global telomere maintenance, but instead have a more restricted role in ALT cell telomere maintenance by recombination.
To test whether depletion of MUS81 affects telomere length homeostasis, we performed a quantitative (Q)-FISH assay on metaphase nuclei using a telomere-specific peptide nucleic acid (PNA) probe. We did not observe significant telomere length changes in shMUS81-transduced GM847 cells ( Supplementary Information, Fig. S5A ); this included changes in average telomere length and the frequency of shorter (< 5 kb) or longer telomeres (> 50 kb). Consistently, telomere restricted fragment (TRF) analysis showed there was no detectable change in telomere length after depletion of MUS81 in ALT or non-ALT cells ( Supplementary  Information, Fig. S5B ). We did not observe obvious chromosome endto-end fusion in ALT cells after depletion of MUS81 (data not shown).
These results are consistent with the fact that MUS81-knockdown did not induce the formation of telomere dysfunction-induced foci (γH 2 AX foci formation on telomeres; Supplementary Information, Fig. S6 ), suggesting that MUS81 does not affect telomere end protection in ALT cells. Expression of exogenous human telomerase reverse transcriptase (hTERT) in ALT cells can induce telomerase activity but does not abolish the ALT mechanism 20,21 , suggesting coexistence of ALT and telomerase in hTERT-transfected ALT cells. To investigate the relationship between MUS81-mediated ALT cell proliferation and telomere maintenance, we stably expressed hTERT in U2OS cells. Telomerase was activated in these cells, as detected by the telomeric repeat amplification protocol (TRAP) assay (Fig. 3a ). The colony formation results showed that hTERT expression partially rescued cell growth after depletion of MUS81 ( Fig. 3b ). We also confirmed the results in another ALT cell line (SAOS-2). Expression of hTERT in SAOS-2 rescued cell growth and approximately 70% of cells survived after depletion of MUS81. U2OS cells expressing hTERT still showed a high rate of T-SCE and knockdown of MUS81 decreased the T-SCE rate in these cells ( Fig. 3c ), suggesting that rescue of MUS81mediated ALT cell survival by telomerase is independent of the telomere recombination pathway. Thus, the results support the proposal that MUS81 regulates the growth of ALT cells mainly through maintenance of telomeres by recombination.
To investigate the role of MUS81endonuclease activity in the ALT pathway, we used a MUS81 mutant construct in which Asp 338 and Asp 339 in the VERK domain were replaced with alanine. Consistent with a previous report 15 , no endonuclease activity was detected in haemagglutinin (HA) immunoprecipitates when this construct was tested ( Supplementary  Information, Fig. S7A ). We observed that expression of wild-type MUS81 was sufficient to rescue the incidence of T-SCE in MUS81-depleted GM847 cells (Fig. 4a) . Notably, expression of the mutant MUS81 did not significantly affect T-SCE frequency, indicating that the endonuclease activity is key for the function of MUS81 on telomere recombination in ALT cells. Furthermore, we proposed that the endonuclease activity of MUS81 is required for the viability of ALT cells. U2OS cells transduced with shMUS81-B (targeting in 3'UTR region) were infected with lentiviral particles containing MUS81 wild-type or mutant protein. Expression of wild-type MUS81 entirely restored viable cell colonies to the levels seen in cultures transduced with a control shRNA vector ( Fig. 4b ; Supplementary  Information, Fig. S7C ), demonstrating that the expression of wild-type MUS81 rescues cell growth from shMUS81-induced arrest. In contrast, the MUS81 endonuclease-dead mutant did not significantly rescue cell growth after MUS81 depletion. Thus, these results indicate that MUS81 enzymatic activity is required for ALT cell survival and telomere recombination.
We used a proteomics approach to detect MUS81-interacting partners in the ALT pathway. A stable U2OS cell line expressing His-and Flagtagged MUS81 was grown. After purification using the His-and Flag-tags with chromatography columns, the MUS81 immunoprecipitates were analysed by liquid chromatography-mass spectrometry (LC−MS/MS). MUS81 binding partners Eme1 and TRF2 were found in the MUS81 complex. Furthermore, we found that endogenous MUS81 immunoprecipitated with endogenous TRF2 (Fig. 5a ). Treatment with DNase 1 did not affect the TRF2-MUS81 interaction, excluding bridging effects of nucleic acids. Moreover, the MUS81 immunoprecipitated complex contained TRF2, but not TRF2 ΔB , a dominant-negative mutant of TRF2 lacking the amino-terminal domain (Fig. 5b) , confirming the specificity of the association of MUS81 with TRF2. We then determined whether TRF2 regulates MUS81 enzymatic activity. Immunoprecipitates of MUS81 from U2OS cells alone could cleave ~ 17% of the total D-loop substrates (Fig. 5c ). However, depletion of TRF2 by shRNA significantly enhanced MUS81-mediated cleavage in ALT cells but not in non-ALT cells. More than 43% of the total substrates were cleaved after transduction of shTRF2 into U2OS cells. To exclude the possibility that the putative endonuclease activity detected in the nuclease assays derived from another protein co-immunoprecipitating with endogenous MUS81, HA-tagged MUS81 wild type or mutant was expressed and immunoprecipitations and nuclease assays were performed using an anti-HA antibody. We observed that knockdown of TRF2 also increased the nuclease activity of HA-MUS81 ( Supplementary Information, Fig. S7A ). Thus, our results suggest that TRF2 may inhibit the enzymatic activity of MUS81. In addition, depletion of TRF2 increased the MUS81-mediated cleavage of a 3' flap substrate generated by telomere or non-telomere sequences ( Supplementary Information, Fig. S7B ), indicating that inhibition of MUS81-enzymatic activity by TRF2 is not sequence specific. Quantitative western blotting analysis showed equivalent amounts of immunoprecipitated MUS81 from cells with or without shTRF2 ( Fig. 5c ), suggesting that TRF2 does not affect the expression levels of MUS81.
Next, we tested whether recombinant TRF2 regulated the binding of HA-MUS81 to DNA structures. Immunoblotting analysis with an anti-HA antibody showed that in the absence of TRF2, HA-MUS81 was associated with biotinylated DNA substrates, as retrieved by streptavidin beads (Fig. 5d ; Supplementary Information, Fig. S7D ). The addition of TRF2 inhibited the binding of HA-MUS81 to DNA in a dose-dependent manner. These data indicate that TRF2 may suppress MUS81 endonuclease activity through inhibition of MUS81 binding to DNA substrates. To confirm the results in vivo, ChIP assays were performed to determine whether TRF2 regulates the ability of MUS81 to bind to telomeric DNA. Knockdown of TRF2 increased the telomere-bound levels of MUS81 (Fig. 5e ). Thus, our results suggest that TRF2 inhibits the enzymatic activity of MUS81 by regulating its loading onto telomeres during the telomere recombination process.
To investigate the functional relationship between TRF2 and MUS81, we examined their effects on telomere recombination. The T-SCE rate increased by 20% in GM847 cells after depletion of TRF2 (Fig. 5f) , suggesting that TRF2 suppresses telomere recombination in ALT cells, consistent with a previous model 22, 23 . Knockdown of MUS81 decreased the rate of T-SCE in cells expressing shTRF2 (Fig. 5f) , demonstrating that TRF2-mediated telomere recombination requires MUS81 in ALT cells.
We did not observe a significant change in telomere circle (t-circle) formation after depletion of MUS81 ( Supplementary Information,  Fig. S8 ), suggesting that t-circles are not involved in MUS81-mediated ALT cell survival. However, as the level of t-circles may have been insufficient for detection we cannot rule out a role for MUS81 in their formation. TRF2 mediates t-loop formation and disruption of t-loop by the TRF2 ΔB mutant generates t-circles 3, 24, 25 . MUS81 does not interact with TRF2 ΔB , implying that MUS81 endonuclease activity may be involved in the TRF2-mediated disruption of t-loop.
In summary, our results demonstrate that MUS81 is specifically involved in telomere recombination and in the maintenance of ALT cell survival. We propose a model where telomeres move into APBs during G2 for recombination-based maintenance. MUS81 is recruited into recombination sites to cleave recombination structures and TRF2 negatively regulates the enzymatic activity of MUS81 to balance this process. In this manner, ALT cells maintain their telomeres and extend their proliferative lifespans.
METHODS
Cell culture, western blotting analysis and immunoprecipitation assays. ALT cell lines (U2OS, GM847 and SAOS-2) and non-ALT cell lines (MCF7, HT1080 and HeLa) were cultured in their respective media (Clontech). Mus81 +/+ and Mus81 -/-MEFs expressing human papillomavirus type 16 E6 were obtained from Clare H. McGowan (Scripps Research Institute, CA) 26 . Cells synchronized at the G1/S boundary by a double thymidine block were released into the cell cycle and then fixed at specific times. An additional block, Hoechst 33342, enriched cells at G2 (ref. 10) . Methionine restriction was performed as described previously 9 . For FACS analysis, arrested cells were prepared as a single-cell suspension, fixed in 70% ethanol on ice and incubated in 1 ml propidium iodide buffer (propidium iodide 25 μg ml -1 , 0.1% NP-40 and 1 mg ml -1 RNAse). Western blotting and immunoprecipitation were performed as described previously 27 .
Lentiviral shRNA constructs and antibodies. MUS81 and TRF2 shRNAs were designed and cloned into the lentiviral construct (Sigma). The following shRNAs were used: shMUS81-A at MUS81 cDNA (accession number NM 025128), positions 973-993 (5'-GAGTTGGTACTGGATCACATT-3'); shMUS81-B, positions 1930-1950 (5'-TGTCACCAGTTGGTCCTCATC-3') and shTRF2 at TRF2 cDNA (accession number NM 005652), positions 615-635 (5'-CCATCCTGTTATCCAGAACTT-3'). The following antibodies were used: anti-mouse MUS81 (1:50 dilution; abCAM), anti-rabbit MUS81 (1:100 dilution; gift from C. H. McGowan), anti-PML (1:300 dilution), anti-nucleoli/C23 (1:300 dilution; Santa Cruz), anti-TRF1 (1:300 dilution; Sigma), anti-BrdU (1:50 dilution; BD) and anti-TRF2 (1:300 dilution; Oncogene).
Colony formation, BrdU incorporation and TUNEL assays.
For the colony formation assay, lentivirus-infected cells were seeded equally into 60-mm dishes (duplicate) and after two weeks the cell colonies were stained with 0.05% crystal violet and counted. For BrdU incorporation analysis, cells were cultured in 4-well chamber slides, BrdU (100 μM) was added to the culture medium for 30 min before cells were fixed with 4% paraformaldehyde. DNA was denatured by two consecutive 15-min treatments with HCl (4 M). After washing, slides were incubated with an anti-BrdU antibody (1:50 dilution) at room temperature for 30 min, and then with a secondary antibody at room temperature for 30 min. Slides were covered with mounting medium and evaluated by fluorescence microscopy. The terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labelling (TUNEL) assay was performed with TUNEL assay kit (Roche).
Immunofluorescence microscopy and telomeric DNA-FISH assays. Cells were cultured on 4-well chamber slides and immunofluorescence microscopy staining was performed as described previously 9 . Samples were pre-extracted in 0.5% TritonX-100/phosphate-buffered saline (PBS) for 1 min on ice. For combined telomeric DNA-FISH, after immunostaining, slides were fixed, treated with ribnuclease A (RNase A; 0.5 μg ml -1 ) in 2×SSC (0.3 M NaCl and 30 mM sodium citrate) for 45 min at 37 °C, and dehydrated in 70%, 80% and 100% ethanol. After denaturing at 80 °C for 3 min, slides were hybridized for 2 h in hybridization solution containing a Tel-C PNA telomere probe (0.3 μg ml -1 ; Applied Biosystems) with 70% formamidine, 1% bovine serum albumin (BSA) and Tris (10 mM at pH 7.2). Next, slides were washed, dehydrated and covered with anti-fading DAPI mounting media.
Telomere Q-FISH and T-SCE (CO-FISH) analysis.
Cells were seeded to 40% confluency and cultured for 26 h with BrdU (30 μM; CO-FISH) or without BrdU (Q-FISH). For the preparation of metaphase cells, cells were incubated with colcemid (0.1 μg ml -1 ) for 3 h before hypotonic shock in 0.56% KCl for 10 min at 37 °C. Samples were then fixed twice in methanol/acetic acid (3:1) for 10 min at room temperature. Metaphase spreads were prepared by dropping fixed cells onto cleaned glass slides. Telomere Q-FISH was performed as described previously 28 .
CO-FISH was performed as described previously 29 . Briefly, after staining with Hoechst 33258 (0.5 μg ml -1 ; Sigma) and exposure to ultra-violet light for 30 min, newly synthesized DNA strands were degraded by treating slides with exonuclease III (3 U μl -1 ) at room temperature for 30 min. Slides were washed and digested in 0.05% pepsin (dissolved in 0.005 M HCL) at 37 °C for 10 min. For the first staining, a FITC-OO-(CCCTAA) 3 PNA probe was used in hybridization buffer (0.3 μg ml -1 probe, 1% blocking buffer and 10 mM Tris at pH 7.2) at room temperature for 2 h. Slides were then washed and fixed again before complement staining with Cy3-OO-(TTAGGG) 3 and covering with anti-fading DAPI mounting.
ChIP assays. Cells were cultured in 15 -cm plates and a ChIP assay was performed using ChIP assay kit (Upstate) according to the manufacturer's instructions. ChIP samples were passed through Bio-Dot apparatus by vacuum and loaded on NY+ membrane (NEN Life Science). The blots were fixed by UV crosslink and hybridized with a 32 P labelled telomere DNA probe 27 . An Alu probe was used to rehybridize with the blots after the previous probe was stripped off.
TRF and 2-D gel assays. Genomic DNA was isolated following standard procedures 30 and digested with HinfI. Samples were separated by electrophoresis on 0.5% agarose gel at 1 V cm -1 for 18-20 h. For the TRF assay, alkaline transfer was performed. For the 2D gel assay, gels containing DNA samples were cut, transfered to 1% agarose gel and run for the secondary dimension at 5 V cm -1 for 2.5 h, before an alkaline transfer was conducted. Membranes were hybridized with a 32 P labelled telomere probe.
MUS81 endonuclease assay.
Oligonucleotides were labelled using the T4 PNK end labelling method with [γ-32 P]ATP. DNA structures were generated by annealing labelled oligonucleotides to their complimentary sequence in annealing buffer (50 mM Tris-HCl at pH 7.5, 50 mM NaCl and 10 mM MgCl 2 ) at 95 °C for 4 min, 65 °C for 10 min, 37 °C for 10 min, 26 °C for 10 min and 4 °C for 10 min. The substrate products were purified using polyacrylamide gel. A non-telomere 3'-flap sequence was used as described previously 31 (telomere 3'-flap sequences are available on request). A D-loop structure was used and an endonuclease assay was performed as described previously 15, 32 , but with modifications. Briefly, antibodies (2 μg) were used in each immunoprecipitation with cell lysates (1 mg). MUS81 immunoprecipitates were washed three times in lysis buffer (50 mM Tris-HCl at pH 8.0, 120 mM NaCl and 0.05% NP-40) and two times in reaction buffer (20 mM Tris-HCl at pH 8.0, 100 mM NaCl, 10 mM MgCl 2, , 0.2 mM dithiothreitol and 5% glycerol). Reactions were initiated by adding labelled DNA substrates (1 nM) into the reaction volume (25 μl) and incubating for 30 min at 37 °C. Reactions were stopped in 5× stop solution (10 mg ml -1 proteinase K, 2.5% SDS, 50 mM Tris-HCl at pH 7.5 and 25 mM EDTA) at 37 °C for 15 min. Products were separated by electrophoresis in 1×TBE 10% polyacrylamide gel (3'-flap substrate) or with Urea (7 M ; D-loop substrate).
MUS81-TRF2
in vitro DNA binding assay. D-loop and 3' flap telomeric DNA substrates were biotinylated (BioServer Biotechnologies). In vitro translated HA-MUS81 (2 μL; Promega) and biotinylated DNA substrates (0.1 pmol) were incubated in the absence or presence of various amounts of recombinant TRF2 for 30 min. The biotinylated DNA substrates were retrieved with streptavidin beads, and the unbound proteins were washed away with binding buffer. Buffers and binding procedures were described previously 33 . Biotinylated DNA-bound HA-MUS81 was detected by western blotting.
Affinity purification and LC-MS/MS analysis of MUS81 associated proteins.
A stable cell line expressing His-and Flag-tagged MUS81 was grown. After purification using His-and Flag-tags with chromatography columns, approximately 1 mg of protein was obtained from 125 ml of lysates. LC−MS/MS was carried out by nanoflow reverse-phase liquid chromatography (RPLC) coupled online with a quadrupole-orthogonal-time-of-flight tandem mass spectrometer (QSTAR XL, Applied Biosystems/MDS Sciex). The MS/MS spectra were subjected to an inhouse MASCOT server for database searching, and the results were compiled, validated and summarized using in-house software. 
Figure S4
MUS81-deficiency does not induce telomere loss and telomere recombination in non-ALT cells. Telomere-FISH assay and T-SCE assay were performed to evaluate telomere loss and T-SCE rate in telomerase positive cells (MCF7 and HT1080) with or without expression MUS81-shRNAs. Depletion of MUS81 did not induce telomere loss and did not change T-SCE rate in these non-ALT cells. Mus81 +/+ and Mus81 -/-MEFs were also used and there were no significant difference in telomere loss and T-SCE rate.
Figure S5
Effects of MUS81 on telomere length. A. Quantitative FISH assay indicated that knockdown of MUS81 did not affect telomere length distribution in GM847 cells. Maps illustrated telomere length distribution range in cells after infection with lentiviral vector or MUS81-A shRNA for one and three weeks. Average telomere length and telomere distribution showed in the Table (the lower panel) . * SD. Quantitative data represent three independent experiments (mean ± S.D.). B. Telomere length analysis by TRF assay in GM847 and MCF7 cells. After one or three weeks stably expressing MUS81-A shRNA or vector control, genomic DNA were digested by Hinf I and separated by pulse-electrophoresis. Southern blot were performed with telomeric DNA probe. Quantitative data represent five independent experiments (mean ± S.D.).
Figure S6
Depletion of MUS81 does not induce telomere dysfunctional induced foci in ALT cells. U2OS cells transduced with control shRNA, MUS81-shRNAs or POT1-shRNA were immunostained with anti-γ-H2AX mouse monoclonal antibody (green) together with anti-TRF1 antibody (red). The nuclei were counterstained with DAPI.
Figure S7
A. Depletion of TRF2 increases the endonuclease activity of MUS81 in ALT cells. HA-tagged MUS81 wild-type (WT) and nuclease dead mutant constructs (338A/339A) (Mu) were expressed in U2OS and HeLa cells. Then, TRF2-shRNA or control shRNA vector was expressed in the cells. The endonuclease activity assay was carried out by incubating the 32 P 3'flap telomeric DNA sequence substrate with immunoprecipitates of anti-HA from cell lysates. Quantitative data were summarized from three independent experiments (mean ± S.D.). Equivalent amounts of immunoprecipitated HA-MUS81 were used, as determined by WB analysis (data not shown).
The decreased expressing levels of TRF2 protein by TRF2-shRNA were confirmed by WB analysis (data not shown). B. The endonuclease activity assay was carried out by incubating the 32 P 3'-flap telomeric DNA sequence substrate (the right panel) and non-telomeric DNA sequence substrate (the left panel) with immunoprecipitates of either anti-MUS81 or IgG from U2OS cell lysates in the presence or absence of TRF2-shRNA expression. Quantitative data represent three independent experiments (mean ± S.D.).
C. MUS81 wild-type, but not the mutant, rescues the ALT cell growth arrest induced by depletion of MUS81. shMUS81-B (in the 3'UTR region) were expressed in U2OS cells for three days and then wild-type or mutant MUS81 were over-expressed in these cells. After two weeks with drug-selection, cell colonies were stained and counted. 7) . HA-MUS81 was detected by WB with the anti-HA antibody. Input, 50% of the total HA-MUS81 used in each reaction (lane 1). The DNA substrates made by telomere sequence were showed in the upper panel and nontelomere sequence in the lower panel.
Figure S8
Knockdown of MUS81 does not affect t-circle formation. MUS81-A shRNA or vector control was stably expressed in GM847 cells for 2 weeks. 2-D gel analysis was conducted to detect t-circle formation.
Figure S9
Full scans of Western blot data.
